Large-scale differentiation of iPSC-derived motor neurons from ALS and control subjects

从ALS患者和对照组受试者中大规模分化iPSC衍生的运动神经元

阅读:5
作者:Michael J Workman ,Ryan G Lim ,Jie Wu ,Aaron Frank ,Loren Ornelas ,Lindsay Panther ,Erick Galvez ,Daniel Perez ,Imara Meepe ,Susan Lei ,Viviana Valencia ,Emilda Gomez ,Chunyan Liu ,Ruby Moran ,Louis Pinedo ,Stanislav Tsitkov ,Ritchie Ho ,Julia A Kaye ,Jeffrey D Rothstein ,Steven Finkbeiner ,Ernest Fraenkel ,Dhruv Sareen ,Leslie M Thompson ,Clive N Svendsen

Abstract

Using induced pluripotent stem cells (iPSCs) to understand the mechanisms of neurological disease holds great promise; however, there is a lack of well-curated lines from a large array of participants. Answer ALS has generated over 1,000 iPSC lines from control and amyotrophic lateral sclerosis (ALS) patients along with clinical and whole-genome sequencing data. The current report summarizes cell marker and gene expression in motor neuron cultures derived from 92 healthy control and 341 ALS participants using a 32-day differentiation protocol. This is the largest set of iPSCs to be differentiated into motor neurons, and characterization suggests that cell composition and sex are significant sources of variability that need to be carefully controlled for in future studies. These data are reported as a resource for the scientific community that will utilize Answer ALS data for disease modeling using a wider array of omics being made available for these samples.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。